$216.98
$0.00 (0.00%)
End-of-day quote: 05/03/2024
NYSE:RMD

ResMed Inc Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$4.22B $3.58B $3.20B $2.96B $2.61B $2.34B $2.07B $1.84B $1.68B $1.55B $1.51B $1.37B $1.24B $1.09B $920.74M $835.40M $716.33M $607.00M $425.51M $339.34M
GM % Gross Margin %
56.50% 57.68% 59.10% 59.77% 58.95% 58.21% 58.15% 58.00% 60.24% 63.65% 62.11% 59.97% 59.81% 60.01% 60.15% 59.48% 62.01% 62.09% 64.60% 63.87%
OM Operating Margin
27.28% 28.01% 28.70% 27.36% 24.40% 23.94% 22.10% 23.70% 24.38% 26.46% 25.06% 21.51% 21.65% 22.28% 21.05% 18.01% 20.92% 21.94% 25.45% 25.30%
EPS Earnings Per Share
$0.00 $6.44 $5.79 $5.33 $4.76 $3.64 $3.53 $2.82 $2.68 $2.57 $2.47 $2.27 $1.78 $1.49 $1.28 $1.00 $0.76 $0.72 $0.71 $0.52 $0.41
Div. Dividends
$1.80 $1.68 $1.56 $1.56 $1.50 $1.42 $1.32 $1.20 $1.12 $1.00 $0.68 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
27.95% 29.02% 29.27% 32.77% 41.21% 40.23% 46.81% 44.78% 43.58% 40.49% 29.96% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sha. Shares
147.06m 146.41m 145.65m 144.89m 143.65m 142.68m 142.17m 140.66m 140.47m 140.3m 142.01m 142.02m 151.67m 151.35m 150.5m 151.95m 155.23m 151.54m 140m 135.43m
OCF Operating Cash Flow
$693.30M $351.15M $736.72M $802.26M $459.05M $505.03M $414.05M $547.93M $383.18M $391.27M $402.82M $383.16M $283.19M $188.21M $238.88M $137.84M $91.11M $99.03M $71.08M $76.54M
FCF Free Cash Flow
$573.63M $216.31M $634.01M $706.93M $390.34M $442.45M $351.83M $489.40M $320.68M $318.55M $339.24M $336.02M $216.58M $131.35M $127.58M $60.83M $13.14M $-4.82M $31.39M $19.29M
FCFS Free Cash Flow Per Share
$3.81 $1.34 $4.27 $4.82 $2.67 $3.04 $2.42 $3.42 $2.22 $2.19 $2.32 $2.21 $1.38 $0.84 $0.81 $0.36 $0.06 $-0.05 $0.21 $0.13